IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-0-387-30107-5_10.html
   My bibliography  Save this book chapter

Data Monitoring in the AIDS Clinical Trials Group Study #981: Conflicting Interim Results

In: Data Monitoring in Clinical Trials

Author

Listed:
  • Dianne M. Finkelstein

    (Massachusetts General Hospital, Biostatistics Center
    Harvard Medical School)

Abstract

In 1989, the NIH sponsored AIDS Clinical Trials Group (ACTG) mounted a large prospective randomized trial (known as ACTG 981) to compare fluconazole (200 mg daily) with clotrimazole lozenges (10mg, five times daily) for prevention of invasive fungal infections in patients with advanced HIV disease. At the fourth DSMB review of the study in November 1992, the patients on fluconazole had a significantly lower risk of invasive, serious and superficial fungal infections, but a higher mortality rate than the patients on clotrimazole. The DSMB recommended keeping the study open in spite of the fact that a boundary had been crossed for the primary endpoint. The final analysis of this study, published in the New England Journal of Medicine, reported that the trial gave evidence of the superiority of fluconazole in preventing the most serious fungal infections, but did not show an advantage in reducing overall mortality, thus vindicating the recommendations of the DSMB to keep the trial open until the planned follow-up had been completed. This paper is a review of the DSMB process for this study, and how the Board dealt with the challenges of interpretation of apparently contradictory evidence on treatment efficacy.

Suggested Citation

  • Dianne M. Finkelstein, 2006. "Data Monitoring in the AIDS Clinical Trials Group Study #981: Conflicting Interim Results," Springer Books, in: David L. DeMets & Curt D. Furberg & Lawrence M. Friedman (ed.), Data Monitoring in Clinical Trials, chapter 0, pages 109-117, Springer.
    • Handle: RePEc:spr:sprchp:978-0-387-30107-5_10
    DOI: 10.1007/0-387-30107-0_10
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-0-387-30107-5_10. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.